Mitochondrial mutagenesis in BCR-ABL1-expressing cells sensitive and resistant to imatinib

• Authors: Janusz Blasiak , Grazyna Hoser , Jolanta Bialkowska-Warzecha , Elzbieta Pawlowska , Tomasz Skorski
• Languages of publication: EN

Abstracts

EN

Imatinib revolutionized the treatment of chronic myeloid leukemia (CML) with the expression of the BCR-ABL1 tyrosine kinase, but imatinib resistance is an emerging problem. Imatinib can hinder the inhibitory effects of BCR-ABL1 on mitochondrial apoptotic pathway, so mitochondrial mutagenesis can be important for its action. To explore the mechanisms of imatinib resistance we created a mouse-derived CML model cells consisting of parental 32D cells (P) and cells transfected with the BCR-ABL1 gene (S cells) or its variants with the Y253H or T315I mutations (253 and 315 cells, respectively), conferring resistance to imatinib. A fraction of the S cells was cultured in increasing concentrations of imatinib, acquiring resistance to this drug (AR cells). The 253, 315 and AR cells, in contrast to S cells, displayed resistance to imatinib. We observed that the T315I cells displayed greater extent of H2O2-induced mtDNA damage than their imatinib-sensitive counterparts. No difference in the sensitivity to UV radiation was observed among all the cell lines. A decrease in the extent of H2O2-induced mtDNA damage was observed during a 120-min repair incubation in all cell lines, but it was significant only in imatinib-sensitive and T315I cells. No difference in the copy number of mtDNA and frequency of the 3,867-bp deletion was observed and genotoxic stress induced by H2O2 or UV did not change this relationship. In conclusion, some aspects of mtDNA mutagenesis, including sensitivity to oxidative stress and DNA repair can contribute to imatinib resistance in BCR-ABL1-expressing cells.

Keywords

EN

Imatinib; chronic myeloid leukemia; BCR-ABL1 gene

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2016
• Volume: 63
• Issue: 2
• Pages: 365-370

Dates

published

2016

received

2015-09-15

revised

2015-12-16

accepted

2015-12-18

(unknown)

2016-01-12

Contributors

author

Janusz Blasiak

• Department of Molecular Genetics, University of Lodz, Łódź, Poland

author

Grazyna Hoser

• Department of Flow Cytometry, Medical Center for Postgraduate Education, Warsaw, Poland

author

Jolanta Bialkowska-Warzecha

• Department of Infectious and Liver Diseases, Medical University of Lodz, Łódź, Poland

author

Elzbieta Pawlowska

• Department of Orthodontics, Medical University of Lodz, Łódź, Poland

author

Tomasz Skorski

• Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA 19140, USA

References

• Alexeyev M, Shokolenko I, Wilson G, LeDoux S (2013) The maintenance of mitochondrial DNA integrity - critical analysis and update. Cold Spring Harb Perspect Biol 5: a012641. doi: 10.1101/cshperspect.a012641.
• Ballinger SW, Van Houten B, Jin GF, Conklin CA, Godley BF (1999) Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp Eye Res 68: 765-772.
• Bixby D, Talpaz M (2011) Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia 25: 7-22. doi: 10.1038/leu.2010.238.
• Blasiak J, Hoser G, Bialkowska-Warzecha J, Pawlowska E, Skorski T (2015) Reactive oxygen species and mitochondrial DNA damage and repair in BCR-ABL1 cells resistant to imatinib. BioRes Open Access 4: 334-342. doi: 10.1089/biores.2015.0022.
• Brady N, Gaymes TJ, Cheung M, Mufti GJ, Rassool FV (2003) Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Cancer Res 63: 1798-1805.
• Druker BJ (2008) Translation of the Philadelphia chromosome into therapy for CML. Blood 112: 4808-4817. doi: 10.1182/blood-2008-07-077958.
• Gredilla R, Bohr VA, Stevnsner T (2010) Mitochondrial DNA repair and association with aging - an update.Exp Gerontol 45: 478-488. doi: 10.1016/j.exger.2010.01.017.
• Griaud F, Williamson AJ, Taylor S, Potier DN, Spooncer E, Pierce A, Whetton AD (2012) BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response. J Proteomics 77: 14-26. doi: 10.1016/j.jprot.2012.06.003.
• Hou L, Zhu ZZ, Zhang X, Nordio F, Bonzini M, Schwartz J, Hoxha M, Dioni L, Marinelli B, Pegoraro V, Apostoli P, Bertazzi PA, Baccarelli A (2010) Airborne particulate matter and mitochondrial damage: a cross-sectional study. Environ Health 9: 48. doi: 10.1186/1476-069X-9-48.
• Kamenisch Y, Berneburg M (2013) Mitochondrial CSA and CSB: protein interactions and protection from ageing associated DNA mutations. Mech Ageing Dev 134: 270-274. doi: 10.1016/j.mad.2013.03.005.
• Kang D, Hamasaki N (2002) Maintenance of mitochondrial DNA integrity: repair and degradation. Curr Genet 41: 311-322.
• Kamenisch Y, Fousteri M, Knoch J, von Thaler AK, Fehrenbacher B, Kato H, Becker T, Dollé ME, Kuiper R, Majora M, Schaller M, van der Horst GT, van Steeg H, Röcken M, Rapaport D, Krutmann J, Mullenders LH, Berneburg M (2010) Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med 207: 379-390. doi: 10.1084/jem.20091834.
• Kazachkova N, Raposo M, Montiel R, Cymbron T, Bettencourt C, Silva-Fernandes A, Silva S, Maciel P, Lima M (2013) Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease. Neurodegener Dis 11: 206-214. doi: 10.1159/000339207.
• Kluza J, Jendoubi M, Ballot C, Dammak A, Jonneaux A, Idziorek T, Joha S, Dauphin V, Malet-Martino M, Balayssac S, Maboudou P, Briand G, Formstecher P, Quesnel B, Marchetti P (2011) Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells. PLoS One 6: e21924. doi: 10.1371/journal.pone.0021924.
• Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M, Blasiak J, Skorski T (2006) BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 108: 319-327.
• Lipton JH, Bryden P, Sidhu MK, Huang H, McGarry LJ, Lustgarten S, Mealing S, Woods B, Whelan J, Hawkins N (2015) Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors. Leuk Res 39: 58-64. doi: 10.1016/j.leukres.2014.10.005.
• Liu J, Fang H, Chi Z, Wu Z, Wei D, Mo D, Niu K, Balajee AS, Hei TK, Nie L, Zhao Y (2015) XPD localizes in mitochondria and protects the mitochondrial genome from oxidative DNA damage. Nucleic Acids Res 43: 5476-5488. doi: 10.1093/nar/gkv472.
• Miething C, Feihl S, Mugler C, Grundler R, von Bubnoff N, Lordick F, Peschel C, Duyster J (2006) The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib. Leukemia 20: 650-657.
• Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S, Cramer K, Reddy MM, Koptyra M, Penserga T, Glodkowska-Mrowka E, Bolton E, Holyoake TL, Eaves CJ, Cerny-Reiterer S, Valent P, Hochhaus A, Hughes TP, van der Kuip H, Sattler M, Wiktor-Jedrzejczak W, Richardson C, Dorrance A, Stoklosa T, Williams DA, Skorski T (2012) Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood 119: 4253-4263. doi: 10.1182/blood-2011-10-385658.
• Nieborowska-Skorska M, Flis S, Skorski T (2014) AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells. Leukemia 28: 2416-2418. doi: 10.1038/leu.2014.249.
• Nieborowska-Skorska M, Hoser G, Hochhaus A, Stoklosa T, Skorski T (2013) Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice. Leukemia 27: 2253-2254. doi: 10.1038/leu.2013.123.
• Rothfuss O, Gasser T, Patenge N (2010) Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach. Nucleic Acids Res 38: e24. doi: 10.1093/nar/gkp1082.
• Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
• Skorski T (2002) BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability. Oncogene 21: 8591-8604.
• Slupianek A, Falinski R, Znojek P, Stoklosa T, Flis S, Doneddu V, Pytel D, Synowiec E, Blasiak J, Bellacosa A, Skorski T (2013) BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability. Leukemia 27: 629-634. doi: 10.1038/leu.2012.294.
• Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, Fishel R, Skorski T (2002) Fusion tyrosine kinases induce therapeutic drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2/M phase and protection from apoptosis. Mol Cell Biol 22: 4189-4201.
• Synowiec E, Hoser G, Wójcik K, Pawlowska E, Skorski T, Blasiak J (2015) UV differentially induces oxidative stress, DNA damage and apoptosis in BCR-ABL1-positive cells sensitive and resistant to imatinib. Int J Mol Sci 16: 18111-18128. doi: 10.3390/ijms160818111.

Identifiers

DOI

10.18388/abp.2015_1189